News
The awards were made under the Company’s 2024 Inducement Stock Incentive Plan, with a grant date and vesting commencement ...
Learn about the factors underlying autoimmune disease and current treatment strategies.
Author Patrick Ussher undertook to understand the latest research in order to cope with his daunting health challenge ...
Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Incyte Corporation (NASDAQ:INCY) with a price target of $68 ...
Even years later, patients whose symptoms were initially dismissed experience distrust and uncertainty with clinicians.
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company with ...
Have you ever heard a mother say, 'My baby will always be a part of me'. It turns out, that’s not just sentiment, it’s ...
6d
The Punch on MSNEssential fatty acids (1)We have a Dacryodes edulis tree (African pear) in our home. Recently, I went to look at the tree and noticed it had started ...
This startup’s mission to extend human life sounds like sci-fi, and investors are betting $20M on it
Tolerance Bio is targeting an often-overlooked organ — the thymus — with cell therapy to help kids with DiGeorge syndrome, and potentially extend lifespan in adults.
This program supports undergraduate, graduate, and medical students conducting lupus-focused research under the guidance of experienced mentors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results